PRISMA-P: Preferred Reporting Items for Systematic Reviews and Meta- Analyses Protocols
|
|
- Rosalind Ellis
- 6 years ago
- Views:
Transcription
1 PRISMA-P: Preferred Reporting Items for Systematic Reviews and Meta- Analyses Protocols Larissa Shamseer, MSc Reporting Guidelines Research Coordinator Knowledge Synthesis Group
2 Overview What is a systematic review protocol? Why are protocols important? Where can protocols be accessed? Protocols & Selective reporting How can reporting guidelines help? PRISMA-P Development Next steps
3 What is a systematic review protocol? States intentions for planned research Description of methodological approach Defines selection criteria Provides operational definitions Document written prior to starting a systematic review (SR) stating rationale, intended purpose and content (i.e. methods)
4 Why are reporting protocols important? Potential to reduce bias & enhance rigour Enhance transparency and confidence in ensuing review Reduce duplication of effort and foster collaboration Assist in critical appraisal Protect/uphold integrity in the research process
5 Where can protocols be accessed? Few options to register protocols; repeated calls for protocol registration... Launched Feb 2011 April 16, 2012: 448 registered protocols from 27 countries 61 from Canada
6 Where can protocols be accessed? Paucity of protocol production & publication <50% (of non-cochrane SRs) on MEDLINE report working from protocols (Moher 2007) Systematic Reviews, open-access journal launched in Feb 2012, publishes protocols (and other SR products) Theme series on importance of protocol registration
7 Selective reporting in primary studies Gaps in evidence of selective reporting in observational studies What we know from the randomized trial literature Major discrepancies in primary outcome reporting between protocols and trial reports: changed in 33-67% of trial reports omitted in 13-42% of trial reports introduced in 11-50% of trial reports (Dwan 2011) When trials are included in systematic reviews, the problem is magnified Do systematic reviews suffer from similar selective reporting?
8 Selective Reporting in SRs Of 60 Cochrane reviews (Issue 3, 2000) 47 had published protocols (Silagy 2002) 91.5% contained a major change from protocol relating to methods and selected outcomes 22% (n=64) of Cochrane reviews published over a 9- month period had discrepant outcomes from their published protocols (Kirkham 2010). 75% changed primary outcome(s) Discrepant outcomes were more likely to be significant than those not changed. Represents a fraction of the problem since majority of SRs are published in peer-reviewed journals
9 Barrier to publishing protocols Authors lack knowledge re: what to include in protocol Existing guidance addresses conduct Existing guidance overwhelming Solution: reporting guidelines!
10 Reporting Guidelines Over the last 25 years, guidance for authors preparing reports for publication have emerged CONSORT Guidance for reporting parallel-group randomized trials SPIRIT Upcoming guidance for reporting protocols of randomized trials; mirrors many CONSORT items PRISMA Reporting guidance for systematic reviews and meta-analyses Newly implemented across all EPC programs PRISMA for Protocols (PRISMA-P) Aims to mirror PRISMA items; reduce workload
11 Scope of PRISMA-P Primarily aimed at reporting protocols of SRs for evaluating clinical intervention efficacy [RCTs] All-encompassing/extrapolation to other SR types
12 Development of PRISMA-P Follows recommended EQUATOR process (Moher J Clin Epi 2010)
13 Initial Steps 1 Paucity of protocol registration and publication outside of select groups Extend PRISMA guidance 2 Review the literature PROSPERO group 3 Funding: AHRQ Canadian Institutes of Health Research
14 Pre-meeting activities 4 27 international experts (journal editors, systematic review methodologists, reporting guideline developers, systematic review funders) 5 PROSPERO Delphi (Booth 2011) 6 Source of items: PROSPERO Delphi, PROSPERO register, PRISMA, IOM CER standards, SPIRIT 7 PRISMA-P meeting: June 2011, Washington, D.C.
15 Face-to-face meeting 8 38 items 22 items Agreement on reporting key methodological items Disagreement/discussion/consensus on many nonscientific issues (e.g. conflict of interest) PRISMA-P Statement & Explanation and Elaboration document planned for 2012 Statement currently being reviewed by steering committee Early support (i.e. planned implementation) by a number of groups
16 Post-meeting activities 9 Checklist refinement currently underway 1 st major revision Oct items 18 items (22 including sub-items) 3 sections: Administrative information Introduction Methods 2 nd major revision March items in progress Phrasing and wording nuances
17 PRISMA-P CHECKLIST
18 Administrative Information Section/topic # Checklist item ADMINISTRATIVE INFORMATION Title 1a Identify the report as a protocol of a systematic review. 1b If an update of a previous review, identify as such Protocol registration 2 Review authors 3 Protocol version 4 Support 5a 5b If registered, name of the registry (e.g. PROSPERO, Joanna Briggs Institute) and registration number Name, institutional affiliation, and physical mailing address of all protocol authors; Whether the report represents the original protocol or an amendment to a previously published protocol Names and contact information of organizations providing monetary or material support for the review (e.g. funding agency, foundation, company, institution), and for review sponsor, if different from funder Role(s) and responsibilities of systematic review funders, sponsors and/or institution(s), if any, in development of review methods and the decision to submit the protocol for publication, including who will have ultimate authority over each of these activities. Contributorship 6 Contributions of protocol authors; state guarantor of protocol Reported on page #
19 Introduction Section/topic # Checklist item INTRODUCTION Rationale 7 Objectives 8 Describe the rationale for the review in the context of what is already known Provide an explicit statement of the question(s) the review will address with reference to participants, interventions, comparisons, outcomes (PICO), as well as study design, setting, and time frame, if applicable Reported on page #
20 Planned Methods Section/topic # Checklist item PLANNED METHODS Eligibility criteria 9 Specify study characteristics (e.g., PICOS, setting, time frame) to be used as criteria for eligibility for review, giving rationale Information sources Search strategy Study selection process Data management & collection 10 Describe all intended information sources (e.g., names of electronic databases, unpublished literature sources, included study authors) in the search and planned date of search 11 Present full search strategy to be used for at least one electronic database, including any planned limits (e.g., years considered, language, publication type), such that it could be repeated 12 State the process that will be used for selecting studies (e.g. abstract and full text consideration, independently, in duplicate). 13a Describe planned method of extracting data from reports (e.g., piloting forms, independently, in duplicate), any processes for obtaining and confirming data from investigators and how data will be managed. Data items 14 List and define all variables for which it is intended data will be sought (e.g., PICO, funding sources), any anticipated data assumptions and simplifications, and any anticipated prioritization of review outcomes (e.g., primary, secondary). Reported on page #
21 Planned methods (cont d) Section/topic # Checklist item PLANNED METHODS Risk of bias in individual studies 15 Describe anticipated methods for assessing risk of bias of individual studies (including whether this will be done at the study or outcome level), and how this information is to be used in any data synthesis. Reported on page # Data Synthesis 16a 16b Reporting biases 17 Strength of evidence Conditions under which data will be quantitatively synthesized, including any planned exploration of completeness and/or consistency (e.g. I 2 ) If data are appropriate for synthesis, describe planned summary measures, methods of synthesis, and additional analyses (e.g. sensitivity or subgroup analyses, meta-regression) 16c If quantitative synthesis is not appropriate, type of summary planned 18 Specify any planned assessment of risk of bias (e.g., publication bias across studies, selective reporting within studies) and their potential impact on overall findings if present Describe how confidence in cumulative evidence across studies will be assessed (e.g., using GRADE tool), if planned.
22 Next steps Will approach current PRISMA endorsers Standard endorsement text Develop & pilot etool to facilitate use by authors, peer reviewers, editors Evaluate effect of endorsement
23
24 etools Why? DM is into colour! Poor implementation to date
25 Steering committee David Moher, Director, Ottawa EPC Mike Clarke, Professor, Queen s University Belfast, Ireland Davina Ghersi, Expert Knowledge Development Officer, National Health and Medical Research Council, Australia Lesley Stewart, Director, Centre for Reviews and Dissemination, UK Alessandro Liberati, Professor, University of Modena, Italy Mark Petticrew, Professor, London School of Hygiene and Tropical Medicine, UK Paul Shekelle, Director, Southern California Evidence-based Practice Centre Project Coordinator: Larissa Shamseer, Ottawa EPC
26 EPC PRISMA-P participants Stephanie Chang, Agency for Healthcare Research and Quality (Rockville, USA) Mark Helfand, Oregon Evidence-based Practice Centre (Portland, USA) Joseph Lau, Tufts Medical Centre Evidence-based Practice Centre (Boston, USA) Kathleen Lohr, Research Triangle Institute-University of North Carolina Evidence-based Practice Centre (Research Triangle Park, USA) Jennifer Tetzlaff, Ottawa Evidence-based Practice Centre (Ottawa, Canada) Thomas Trikalinos, Tufts Medical Centre Evidence-based Practice Centre (Boston, USA) Evelyn Whitlock, Oregon Evidence-based Practice Centre and United States Preventive Services Task Force (Portland, USA)
27 Other PRISMA-P Participants Douglas G Altman, DSc, Centre for Statistics in Medicine (Oxford, UK) Alison Booth, Centre for Reviews and Dissemination, University of York (York, UK) An-Wen Chan, University of Toronto (Toronto, Canada) Tammy Clifford, Canadian Agency for Drugs and Technologies in Health (CADTH) Peter Gøtzsche, Nordic Cochrane Centre (Copenhagen, Denmark) Jeremy Grimshaw, Ottawa Hospital Research Institute (Ottawa, Canada); KT Canada Trish Groves, British Medical Journal (London, UK) Toby Lasserson, Cochrane Editorial Unit (London, UK) Jessie McGowan, University of Ottawa (Ottawa, Canada) Melissa Norton, PLoS Medicine (London, UK) Iveta Simera, EQUATOR Network (Oxford, UK) Bill Summerskill, the Lancet (London, UK)
28 Questions?
TIDieR Reporting Guidelines for Yoga Research
TIDieR Reporting Guidelines for Yoga Research STEFFANY MOONAZ, PHD, C-IAYT DIRECTOR OF CLINICAL AND ACADEMIC RESEARCH DAVID RILEY, MD ADJUNCT PROFESSOR, MARYLAND UNIVERSITY OF INTEGRATIVE HEALTH Introductions
More informationIncreasing value and reducing waste: Addressing inaccessible research
Increasing value and reducing waste: Addressing inaccessible research January 8, 2014 An-Wen Chan, MD DPhil Women s College Research Institute University of Toronto When I had to decide whether to have
More informationIntegrating Existing Reviews into the CADTH Optimal Use Project on HPV Testing for Primary Cervical Cancer Screening
Integrating Existing Reviews into the CADTH Optimal Use Project on HPV Testing for Primary Cervical Cancer Screening Rationale for Integrating Existing Reviews As part of the a priori planned methods for
More informationThe knowledge synthesis How can a review and synthesis be systematic? Fredrik Fernqvist Work Science, Business Economics and Environmental Psychology
The knowledge synthesis How can a review and synthesis be systematic? Fredrik Fernqvist Work Science, Business Economics and Environmental Psychology Background The National Food Strategy for Sweden Formas
More informationEvidence of occupational accidents with equipment in mining a systematic review protocol
Evidence of occupational accidents with equipment in mining a systematic review protocol J. Duarte a, J. Santos Baptista b, A. T. Marques c a LAETA, Faculty of Engineering of University of Porto, Porto,
More informationFinding the Evidence: Tools and Techniques for Literature Searching
Finding the Evidence: Tools and Techniques for Literature Searching April 24, 2015 Webinar for SHLA CADTH CADTH is an independent, not-for-profit producer and broker of health technology assessments. Federal,
More informationBayer Corporate Policy: Global Publications Deriving from Clinical Studies in Humans
Bayer Corporate Policy: Global Publications Deriving from Clinical Studies in Humans Overview The key aspects of this Global Publication Policy are commitment to publish; consistent application of authorship
More informationHow is trial registration affecting gjournals?
How is trial registration affecting gjournals? Dr Trish Groves Deputy editor, BMJ & Editor in chief, BMJ Open My competing interests Roles at BMJ contributing to, publicising, and leading implementation
More informationTHANK YOU FOR JOINING ISMPP U TODAY!
THANK YOU FOR JOINING ISMPP U TODAY! The program will begin promptly at 10:00 am EDT August 20, 2013 ISMPP WOULD LIKE TO THANK.. the following Corporate Platinum Sponsors for their ongoing support of the
More informationSystematic Review and Quantitative Synthesis
Systematic Review and Quantitative Synthesis Reporting Systematic Reviews and Meta-Analyses Thu 8 March 2018 09.00-11.00 am. Porjai Pattanittum Epidemiology and Biostatistics Department, Public Health
More informationI T A L I A N J O U R N A L O F P U B L I C H E A L T H. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials Kenneth F. Schulz 1, Douglas C. Altman 2, David Moher 3, for the CONSORT Group 1 1 Family Health International,
More informationScientific journal editor core competencies
Scientific journal editor core competencies My disclosures Founding editor-in-chief, Systematic Reviews On the editorial board of several biomedical journals BMC Medicine Advisory member International
More informationOPTIMAL USE PROGRAM DRUG Therapeutic Review Framework and Process
OPTIMAL USE PROGRAM DRUG Therapeutic Review Framework and Process Version: 3.0 Publication Date: June 27, 2018 Report Length: 16 Pages Revision History From time to time, CADTH may amend the therapeutic
More informationInformation for clinical researchers on transparency of clinical trial reporting
Information for clinical researchers on transparency of clinical trial reporting This document has been produced by leading UK healthcare organisations including the medical Royal Colleges and senior representatives
More informationCS19 KIRSTY LOUDON UNIVERSITY OF STIRLING
CS19 TREATMENT AS USUAL AS THE COMPARATOR IN RANDOMISED CONTROLLED TRIALS: A SCOPING REVIEW OF THE USE OF THE TERM OVER THE PAST FIVE YEARS IN SIX INTERNATIONAL GENERAL MEDICAL TRIAL JOURNALS. KIRSTY LOUDON
More informationSreeram V. Ramagopalan, Andrew P. Skingsley, Lahiru Handunnetthi, Michelle Klingel 2, Daniel Magnus 2, Julia Pakpoor 1, Ben Goldacre 2
SHORT RESEARCH ARTICLE Prevalence of primary outcome changes in clinical trials registered on ClinicalTrials.gov: a cross-sectional study [version 1; referees: 3 approved] Sreeram V. Ramagopalan, Andrew
More information2013 Nobel Laureates. Physiology or Medicine: James E. Rothman, Randy W. Schekman and Thomas C. Südhof. Physics: François Englert and Peter W.
2013 Nobel Laureates Physiology or Medicine: James E. Rothman, Randy W. Schekman and Thomas C. Südhof "for their discoveries of machinery regulating vesicle traffic, a major transport system in our cells
More informationCONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials Kenneth F Schulz, Douglas G Altman, David Moher; for the CONSORT Group Kenneth F Schulz is distinguished scientist
More informationWhite Paper January 2017 META-ANALYSIS FOR HEALTH TECHNOLOGY SUBMISSIONS WORLDWIDE: A REPORT CHECKLIST FOR BEST PRACTICE. Sarah Batson, Neil Webb
05 NETWORK White Paper January 2017 META-ANALYSIS FOR HEALTH TECHNOLOGY SUBMISSIONS WORLDWIDE: A REPORT CHECKLIST FOR BEST PRACTICE Sarah Batson, Neil Webb Network meta-analysis (NMA) is an accepted statistical
More informationUnpacking the evidence behind the AMWA EMWA ISMPP Joint Position Statement. Paul Farrow DPhil CMPP MedComms Networking Brunch Club 5 April 2017
Unpacking the evidence behind the AMWA EMWA ISMPP Joint Position Statement Paul Farrow DPhil CMPP MedComms Networking Brunch Club 5 April 2017 Paul Farrow DPhil CMPP Communications Director at Oxford PharmaGenesis
More informationCanadian Task Force on Preventive Health Care Procedure Manual
Canadian Task Force on Preventive Health Care Procedure Manual October 2011 Page 1 Table of Contents Section 1: Overview of structure and processes... 7 1.1 Function... 7 1.2 Governance... 7 1.3 Overview
More informationJoanna Briggs Institute Comprehensive Systematic Review Training: An Opportunity for Covenant Health
Joanna Briggs Institute Comprehensive Systematic Review Training: An Opportunity for Covenant Health Dr. Ann Syme 1, Danielle Baron 1, Melissa Johnson 2, & Sharna Polard 3 1 Palliative Institute 2 Network
More informationIndirect Comparisons in Economic Evaluations: Experience from the Common Drug Review Julie Blouin, Karen M Lee
Indirect Comparisons in Economic Evaluations: Experience from the Common Drug Review Julie Blouin, Karen M Lee 2009 CADTH Symposium April 6, 2009, Ottawa, ON Presentation Outline Background on indirect
More informationAdvancing Research by Publishing Research Protocols and Negative Studies
Advancing Research by Publishing Research Protocols and Negative Studies Riaz Agha Balliol College, University of Oxford and Department of Plastic Surgery, Guy s and St. Thomas NHS Foundation Trust editor@journal-surgery.com
More informationEvaluation Tools for COMPUS
Evaluation Tools for COMPUS Background The Canadian Optimal Medication Prescribing and Utilization Service (COMPUS) identifies, evaluates, promotes and facilitates best practices in drug prescribing and
More informationResearch reporting and its integration into international policies on research for health in Latin America and the Caribbean (LAC)
Research reporting and its integration into international policies on research for health in Latin America and the Caribbean (LAC) EQUATOR Scientific Symposium 2012 Some slides shown at Ninth Regional
More informationDownloaded from:
Moher, D; Hopewell, S; Schulz, KF; Montori, V; Gotzsche, PC; Devereaux, PJ; Elbourne, D; Egger, M; Altman, DG (2010) CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.
More informationIntroduction I. Rationale
Which outcomes should we measure in cellulitis trials? Results of a systematic review of outcomes included in cellulitis trials and a patient priority setting survey Dr Emma Smith, Centre of Evidence-based
More informationRecruitment of a Managing Editor
3.2.8.5 Recruitment of a Managing Editor This page was updated by Claire Allen in consultation with the MEs Executive on 10 February 2014. This is a template for Review Groups to use and/or modify as they
More informationHow to write and publish a paper
How to write and publish a paper December 2018 Adrian Aldcroft, Editor in Chief, BMJ Open Writing research papers and using reporting guidelines Resources IMRaD Writing style Research to Publication rtop.bmj.com
More informationThe Yale Open Data Access (YODA) Project: Lessons Learned in Data Sharing
The Yale Open Data Access (YODA) Project: Lessons Learned in Data Sharing Grand Rounds: A Shared Forum of the NIH HCS Collaboratory and PCORnet June 30, 2017 Joseph S. Ross, MD, MHS Section of General
More informationTranslational Research - Bench to Trial
TRANSLATION BENCH TRIAL Translational Research - Bench to Trial Marc T. Avey Canadian Institutes of Health Research (Knowledge Translation) Post-doctoral Fellow Clinical Epidemiology Program Ottawa Hospital
More informationWHO Guidelines on "Protecting Workers from Potential Risks of Manufactured Nanomaterials
WHO Guidelines on "Protecting Workers from Potential Risks of Manufactured Nanomaterials Vladimir Murashov Chair, WHO NANOH U.S. National Institute for Occupational Safety and Health Santiago, Chile, November,
More informationIN 2005, THE INTERNATIONAL COMmittee
ORIGINAL CONTRIBUTION Comparison of Registered and Published Primary Outcomes in Randomized Controlled Trials Sylvain Mathieu, MD Isabelle Boutron, MD, PhD David Moher, PhD Douglas G. Altman, DSc Philippe
More informationConsolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
Husereau et al. BMC Medicine 2013, 11:80 GUIDELINE Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement Open Access Don Husereau 1,2,3,15*, Michael Drummond 4, Stavros Petrou
More informationOverview of Good Publication Practice Guidelines, including GPP3: Why should medical writers care?
Overview of Good Publication Practice Guidelines, including GPP3: Why should medical writers care? Teresa Peña, PhD Head, Medical Publications Bristol-Myers Squibb ISMPP Board Chair & GPP3 Author San Antonio,
More informationA systematic review of mentorship programs and their outcomes in psychiatry training
Title: A systematic review of mentorship programs and their outcomes in psychiatry training A systematic review of mentorship programs and their outcomes in psychiatry training Keywords: Mentorship, training,
More informationMaureen Dobbins Jeremy Grimshaw Michael Wilson
Maureen Dobbins Jeremy Grimshaw Michael Wilson Use of systematic reviews by different stakeholder groups hindered by: significant growth in number of systematic reviews dispersion of reviews across large
More informationAnnals of Medicine and Surgery
Annals of Medicine and Surgery 4 (2015) 17e21 Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com Do surgery journals insist on reporting by
More informationTowards Greater International Transparency of Clinical Trials
Karmela Krleza-Jeric,MD, M.Sc., D.Sc. CIHR - IRSC Towards Greater International Transparency of Clinical Trials Short Term Efforts for Long Term Benefits: CIHR trial policy 2010 1 Outline Prospective trial
More informationConsolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement
Contemporary Issues Clinical Therapeutics/Volume 35, Number 4, 2013 POHP Update Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement Don Husereau, BScPharm, MSc 1,2,3 ; Michael
More informationBios 6648: Design & conduct of clinical research
Bios 6648: Design & conduct of clinical research Section 3 - Essential principle 3.2 Treatment allocation (randomization) 3.3 Study quality control 3.4 Trial monitoring: Interim decision and group sequential
More informationHow journals can help to make clinical trials honest, useful, and usable
How journals can help to make clinical trials honest, useful, and usable Special session on sharing IPD from clinical trials: ICTMC/SCT conference May 2017 Liverpool Dr Trish Groves tgroves@bmj.com twitter
More informationEuropean Stroke Journal: Declaration Guidelines for Authors
Table of Contents 1. Human Research and In Vitro Studies... 2 Required Declarations... 2 Example of a completed declarations section... 2 Example of text that should be used if any declaration is not relevant
More informationSyllabus for M.Pharm Clinical Research Semester II
Syllabus for M.Pharm Clinical Research Semester II Clinical Research Methodology Paper I MPCR 201 T Scope After Completion of the course students should be able to understand various practical aspects
More informationCONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
Journal of Clinical Epidemiology 63 (2010) e1ee37 ORIGINAL ARTICLE CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials David Moher a, *, Sally Hopewell
More informationPreferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data The PRISMA-IPD Statement
Clinical Review & Education Special Communication Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data The PRISMA-IPD Statement Lesley A. Stewart, PhD; Mike
More informationYale University. Open Data Access Project
Open Data Access Project A Model for Dissemination and Independent Analysis of Clinical Trial Program Data Funded by a contract with Medtronic, Inc. Session Objectives Why do we need to promote data sharing?
More informationYale University. Open Data Access Project
Open Data Access Project A Model for Dissemination and Independent Analysis of Clinical Trial Program Data Funded by a contract with Medtronic, Inc. Rationale A substantial number of clinical trials are
More informationConflict of Interest. From Evidence to Practice Canadian Prehospital Evidence Based Protocols
From Evidence to Practice Canadian Prehospital Evidence Based Protocols Andrew Travers MD MSc FRCPC Provincial Medical Director Emergency Health Services Halifax, Nova Scotia Conflict of Interest Academic
More informationAPPRAISAL OF GUIDELINES
APPRAISAL OF GUIDELINES for RESEARCH & EVALUATION II Korean Appraisal of Guidelines for Research & Evaluation II INSTRUMENT Steering Committee for Clinical Practice Guideline The AGREE Next Steps Consortium
More informationCourse schedule (4 block days) Room: tbd
Universität Ulm 89069 Ulm Germany Medizinische Fakultät Institut für Epidemiologie und Medizinische Biometrie Leitung: Prof. Dr. D. Rothenbacher http://www.uni-ulm.de/med/epidemiologie-biometrie Gruppe
More informationDownloaded from:
Moher, D; Hopewell, S; Schulz, KF; Montori, V; G?tzsche, PC; Devereaux, PJ; Elbourne, D; Egger, M; Altman, DG (2010) CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel
More informationPositive and Negative Behaviours in Workplace Relationships: A Scoping Review
Positive and Negative Behaviours in Workplace Relationships: A Scoping Review Joan Almost, RN, PhD Assistant Professor, School of Nursing Queen s University Canadian Health Workforce Conference October
More informationBios 6648: Design & conduct of clinical research
Bios 6648: Design & conduct of clinical research Section 3 - Essential principle Lecture schedule Nov 11: Special topics and designs 5.1 Design and analysis of crossover studies 5.2 Design and evaluation
More informationAims and challenges of clinical trial data sharing
Aims and challenges of clinical trial data sharing Facilitating data access to non-industry funded research UCL and Yale meeting: 9 October 2015 London Dr Trish Groves Head of research,
More informationInternational Federation for Emergency Medicine
International Federation for Emergency Medicine ACN 145 437 216 LINKS TO USEFUL RESEARCH TRAINING URLs GENERAL ONLINE RESOURCES Free or very low cost online access to the major journals in biomedical and
More informationPost-trial follow-up methodology in large randomized controlled trials: a systematic review protocol
Llewellyn-Bennett et al. Systematic Reviews (2016) 5:214 DOI 10.1186/s13643-016-0393-3 PROTOCOL Open Access Post-trial follow-up methodology in large randomized controlled trials: a systematic review protocol
More informationCONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
TRIALS RESEARCH Open Access CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials Kenneth F Schulz 1*, Douglas G Altman 2, David Moher 3, the CONSORT Group Abstract
More informationHealth Technology Assessment and Pragmatic Controlled Trials
Health Technology Assessment and Pragmatic Controlled Trials 6 th Annual Meeting of Health Technology Assessment International Singapore june 2009 Associate Professor Eva Draborg Institute of Public Health
More informationOvercome failure to Publish negative finndings: The OPEN project
Overcome failure to Publish negative finndings: The OPEN project For the OPEN Consortium Joerg Meerpohl German Cochrane Centre, Institute of Medical Biometry and Medical Informatics, University Medical
More informationPan African Clinical Trials Registry (PACTR) Amber Abrams, Project Manager South African Cochrane Centre
Pan African Clinical Trials Registry (PACTR) Amber Abrams, Project Manager South African Cochrane Centre Acknowledgements The European and Developing Countries Clinical Trials Partnership (EDCTP) Trial
More informationPublications for payors: what evidence do they really need? Ian Pickles, Strategy Consultant, Complete Clarity
Publications for payors: what evidence do they really need? Ian Pickles, Strategy Consultant, Complete Clarity OBJECTIVES FOR THE SESSION To be able to build payer evidence requirements into publication
More informationEverything You Wanted to Know About ClinicalTrials.gov*
Everything You Wanted to Know About * Deborah A. Zarin, MD Director, National Library of Medicine (*But Were Afraid to Ask) DISCLAIMER Views are mine and do not necessarily represent views of NIH or HHS
More informationDownloaded from:
Moher, D; Hopewell, S; Schulz, KF; Montori, V; Gtzsche, PC; Devereaux, PJ; Elbourne, D; Egger, M; Altman, DG; CONSORT, (2012) CONSORT 2010 explanation and elaboration: Updated guidelines for reporting
More informationThe EQUATOR Network
www.goodreports.org: a new online tool from EQUATOR to help find and use reporting guidelines Presented by Caroline Struthers, UK EQUATOR Centre, Oxford Reducing waste in research: REWARD session, 10 June
More information2014 CLINICAL POLICY UNIT. Dr Vesna Kupresan
2014 CLINICAL POLICY UNIT Dr Vesna Kupresan Healthcare Industry Challenges Medical inflation Cost drivers Aging population Increased utilization of healthcare Growing chronic disease burden Rapid evolution
More informationReporting guidance: Conducting a systematic review for inclusion in the Crime Reduction Toolkit
Reporting guidance: Conducting a systematic review for inclusion in the Crime Reduction Toolkit The Crime Reduction Toolkit 1 is an online repository for systematic reviews focussed on crime reduction.
More informationSunshine on Europe: impact of recent EFPIA and EU guidelines on publication planners. Susan Scott, PhD, CMPP Director, Scott Pharma Solutions Ltd
Sunshine on Europe: impact of recent EFPIA and EU guidelines on publication planners Susan Scott, PhD, CMPP Director, Scott Pharma Solutions Ltd Disclaimer As an independent consultant, the views expressed
More informationStructure and Function Review
Structure and Function Review Paper 3: Cochrane Fields: An Update on proposals [OPEN ACCESS] Document prepared by: Submitted to Steering Group: Purpose of the Paper: Access: Summary of recommendation:
More informationThe CONSORT Statement II
L'Integrità della Ricerca Biomedica nell era dell'evidence-based Health Care Istituti Ortopedici Rizzoli Bologna, 23 novembre 2001 Consolidated olidated standards of Reporting Trial revised The CONSORT
More informationGuiding Principles on the Sharing of Clinical Trial Data. DNDi POLICIES
Guiding Principles on the Sharing of Clinical Trial Data DNDi POLICIES May 2017 I. Preamble DNDi s vision is to improve the quality of life and health of people suffering from neglected tropical diseases
More informationJournal of Clinical Urology (JCU): Declaration Guidelines for Authors
Table of Contents 1. Case Report or Case Series... 2 Required Declarations... 2 Example of a completed declarations section:... 2 Example of text that should be used if any declaration is not relevant
More informationComparative Effectiveness Research and Personalized Medicine: Policy, Science and Business. Setting the Stage. October 28, 2009 Washington, DC
Comparative Effectiveness Research and Personalized Medicine: Policy, Science and Business Setting the Stage October 28, 2009 Washington, DC Clifford Goodman, PhD Vice President clifford.goodman@lewin.com
More informationInvestigator Experiences with the Ethics Review Process of Cluster Randomized Trials: An International Survey
Investigator Experiences with the Ethics Review Process of Cluster Randomized Trials: An International Survey Shazia H. Chaudhry, Monica Taljaard, Jamie C. Brehaut, Jeremy M. Grimshaw, Martin P. Eccles,
More informationImproving the design and reporting of animal studies, tools: ARRIVE Guidelines, EDA and SyRF
Improving the design and reporting of animal studies, tools: ARRIVE Guidelines, EDA and SyRF Dr Nathalie Percie du Sert Information Meeting for Grant Applicants on the Call for Proposals for Confirmatory
More informationBackground: ClincalTrials.gov and the database for Aggregate Analysis of ClincalTrials.gov (AACT)
Background: ClincalTrials.gov and the database for Aggregate Analysis of ClincalTrials.gov (AACT) Background! What is ClinicalTrials.gov?! ClinicalTrials.gov history! Key reporting requirements! Rationale
More informationDisclosures. Objectives 02/06/2017
The 59 th annual meeting of the American Headache Society June 2017 Boston, Massachusetts Migraine Preventive Clinical Trial Data: Interpretation, Misinterpretation, and Integration into Future Study Designs
More informationCochrane Consumer and Communication Group (CCCG) review updating guidance and policy: for authors
Cochrane Consumer and Communication Group (CCCG) review updating guidance and policy: for authors This document contains the 2017 version of the CCCG updating guidance and policy. In 2016, after several
More informationHow to incorporate economic evaluations in clinical practice guidelines: a practical workshop on research methods
How to incorporate economic evaluations in clinical practice guidelines: a practical workshop on research methods Please boot your laptop/tablet and go to: PubMed.gov Shortlink: bit.ly/pubmed ISPOR November
More informationLa campagna Lancet-REWARD: ridurre gli sprechi e premiare il rigore scientifico. Iain Chalmers Coordinator, James Lind Initiative
La campagna Lancet-REWARD: ridurre gli sprechi e premiare il rigore scientifico Some highlights over the past 40 years of my association with Italian colleagues Iain Chalmers Coordinator, James Lind Initiative
More informationThe European Network of Centres of Pharmacoepidemiology & Pharmacovigilance (ENCePP)
The European Network of Centres of Pharmacoepidemiology & Pharmacovigilance (ENCePP) & The Code of Conduct Presented by: Dr Stella Blackburn EMA Risk Management Development and Scientific Lead An agency
More informationCODE OF PRACTICE FOR RESEARCH
CODE OF PRACTICE FOR RESEARCH Dr Diana Leighton REF Manager Professor Andy Young Director of Research & Innovation Services Version 1.0 - September 2010 First approved Academic Board 27 September 2010
More informationCochrane s structure and function reviews a status overview Introduction
Status of the various Structure and Function reviews [OPEN ACCESS] 1 Cochrane s structure and function reviews a status overview Introduction The organization-wide review of the structure and function
More informationCADTH s Proposed Process for the Assessment of Companion Diagnostics
CADTH s Proposed Process for the Assessment of Companion Diagnostics 1. Preamble Companion diagnostics identify subgroups of patients for whom select drugs are likely to be most effective and safe. Based
More informationTHE IMPACT OF THE AFFORDABLE CARE ACT (ACA) ON CANCER RESEARCH, CARE, AND PREVENTION
THE IMPACT OF THE AFFORDABLE CARE ACT (ACA) ON CANCER RESEARCH, CARE, AND PREVENTION William S. Dalton, PhD, MD AACR April 17, 2016 Designing a Federated Model To Support Research & Healthcare Offices
More informationA systematic review of comparisons between protocols or registrations and full reports in primary biomedical research
Li et al. BMC Medical Research Methodology (2018) 18:9 DOI 10.1186/s12874-017-0465-7 RESEARCH ARTICLE Open Access A systematic review of comparisons between protocols or registrations and full reports
More informationHTA Principles Survey Questionnaire
I. Introduction This survey aims to inform health care decision makers in their rational and efficacious applications of health technology assessment (HTA) in Asia, while adhering to key established benchmarks.
More informationS T R E G A Strengthening the Reporting of Genetic Associations
S T R E G A Strengthening the Reporting of Genetic Associations Report on Workshop held June 15-16, 2006 Ottawa, Ontario, Canada, and subsequent work January 31, 2008 Report on Workshop held June 15-16,
More informationModule Guide 2016/17: Statistics for the Oncologist
MSc Oncology Including PG Certificate and PG Diploma Part A: Basic Sciences Module Guide 2016/17: Statistics for the Oncologist Contents 1. Module Details 3 2. Joint Module Leaders and Course Administration
More informationDevelopment and Implications of a Redacted Clinical Trial Protocol for Posting Online With the Published Manuscripts
Development and Implications of a Redacted Clinical Trial Protocol for Posting Online With the Published Manuscripts Namit Ghildyal, Yvette Ng, Craig Tendler, Chris H. Takimoto, Susan Glasser Janssen Research
More informationClinical Trial Registration: A Step towards Transparency and Accountability
ISSN (Print): 2456-7787 Society of Indian Physiotherapists Research Information Clinical Trial Registration: A Step towards Transparency and Accountability Sundar Kumar Veluswamy 1, Abraham Samuel Babu
More informationTechnical Guidance on Clinical Evaluation of Medical Devices
Annex Technical Guidance on Clinical Evaluation of Medical Devices I. Purpose The clinical evaluation of medical devices is the assessment procedure conducted by registration applicants to validate whether
More informationSystematic Reviews: How Accurate Are They and Can We Do Better?
Systematic Reviews: How Accurate Are They and Can We Do Better? Authors: Gerald Borok, PhD, MPH Todd Feinman, MD Iris Tam, PharmD Gerald M. Borok, PhD, MPH Senior Director, Client Solutions Doctor Evidence,
More informationPROSPERO International prospective register of systematic reviews
PROSPERO International prospective register of systematic reviews A realist review to explore how low-income pregnant women use food vouchers from the UK s Healthy Start programme. Heather Ohly, Victoria
More informationCADTH COMMON DRUG REVIEW. Procedure for the CADTH Common Drug Review
CADTH COMMON DRUG REVIEW Procedure for the CADTH Common Drug Review AUGUST 2014 RECORD OF UPDATES TO THE PROCEDURE FOR THE CADTH COMMON DRUG REVIEW Update Original June 2003 1 January 2005 2 July 2005
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Medical Technologies Evaluation Programme
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Medical Technologies Evaluation Programme Sponsor submission of evidence: Evaluation title: Sponsor: Date sections A and B submitted: Date section C submitted:
More informationA critical appraisal of: The Japanese Guidelines for the Management of Sepsis using the AGREE II Instrument
A critical appraisal of: The Japanese Guidelines for the Management of Sepsis using the AGREE II Instrument Created with the AGREE II Online Guideline Appraisal Tool. No endorsement of the content of this
More informationARQUIVOS BRASILEIROS DE CARDIOLOGIA (BRAZILIAN ARCHIVES OF CARDIOLOGY) GUIDELINES FOR PUBLICATION
ARQUIVOS BRASILEIROS DE CARDIOLOGIA (BRAZILIAN ARCHIVES OF CARDIOLOGY) GUIDELINES FOR PUBLICATION 1. The Brazilian Archives of Cardiology (Arq Bras Cardiol) is a monthly publication of the Brazilian Society
More informationHEALTH TECHNOLOGY ASSESSMENT GUIDELINES
HEALTH TECHNOLOGY ASSESSMENT GUIDELINES DRUG SUBMISSION GUIDELINES FOR NEW PRODUCTS, NEW INDICATIONS, AND NEW FORMULATIONS The WellPoint Outcomes Based Formulary SM WellPointNextRx Updated September 2008
More information